BiomaterialsGlomerulosclerosisFocal SegmentalHumansLactic AcidNephrosis
A lactate capture-sensing platform for facilitating early differential diagnosis of minimal change disease and focal segmental glomerulosclerosis in renal diseases.
Jiayi Fan, Bing Zhang, Yongtao Yu, Xiaoqing Yang, Wuduo Zhao, Hang Yuan, Yanjie Huang, Ajuan Yu, Gangfeng Ouyang
Published: 202610.1016/j.biomaterials.2025.123839
Abstract
Minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) are primary glomerular disorders, and currently the invasive renal biopsy combined with gene sequencing are required for definitive diagnosis, which is apparently a suboptimal…
Preview only. Read the full abstract at the source